CONMED Corp
Company Stats
- Market Cap
- $1.4B
- as of Sep 30, 2026
- Shares Outstanding
- 30.0M
- Free Float
- 99.2%
Income Statement
- Revenue
- $1.4B
- Operating Income
- $102.6M
- Net Income
- $47.1M
- EBITDA
- $119.8M
- Revenue Growth, 3Y
- 9.6%
- FCF Margin, 3Y Avg
- 10.4%
- FCF Margin, Worst Year
- 8.5%
Cash Flow
- Free Cash Flow
- $150.9M
- FCF Yield
- 10.9%
- Owner FCF Yield
- 8.9%
Returns & Capital
- Dividends Paid
- $24.7M
- Dividend Yield
- 1.8%
- Dividend Payout, 3Y Avg
- 36.4%
- SBC, 3Y Avg
- $26.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.4B | $150.9M | 11.0% |
| FY2024 | $1.3B | $153.9M | 11.8% |
| FY2023 | $1.2B | $106.3M | 8.5% |
| FY2022 | $1.0B | $11.6M | 1.1% |
| FY2021 | $1.0B | $96.9M | 9.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 22, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back